It should be noted that thismutation is more typical of young patients and can serve as a diagnostic and aprognostic factor, since it allows differentiation of astrocytomas andoligodendrogliomas and also because it is associated with a more benignprognosis (in case of lost ATRX activity) [54]. The gene discussed is ATRX; the disease is astrocytoma (excluding glioblastoma).